Prioritizing early breast cancer detection
Risk Pathways
Risk Assessment
Health System
McLaren Flint expanding its breast cancer screening and risk assessment capabilities with Volpara Risk Pathways
The integration supports the McLaren Flint Comprehensive Breast Care program by providing tools that facilitate early risk identification and care planning.
“At McLaren Flint, early detection is a priority,” said Chris Candela, President and CEO. “By integrating Volpara Risk Pathways, we empower our clinicians with the resources to assess patient risk levels more effectively and ensure that those at higher risk receive the appropriate screenings and interventions.”
